Cargando…

Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation

BACKGROUND: To understand our performance with respect to the collection and reporting of patient-reported outcome (PRO) measure (PROM) data, we examined the protocol content, data completeness and publication of PROs from interventional trials conducted at the Royal Marsden NHS Foundation Trust (RM...

Descripción completa

Detalles Bibliográficos
Autores principales: Lidington, Emma, Hogan, Holly, Gandolfi, Ann, Lawrence, Jane, Younger, Eugenie, Cho, Helena, Peckitt, Clare, Mohammed, Kabir, Matharu, Sheila, Scerri, Lisa, Husson, Olga, Cruickshank, Susanne, Turner, Rachel, Wedlake, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780410/
https://www.ncbi.nlm.nih.gov/pubmed/36547735
http://dx.doi.org/10.1186/s41687-022-00529-9
_version_ 1784856831630245888
author Lidington, Emma
Hogan, Holly
Gandolfi, Ann
Lawrence, Jane
Younger, Eugenie
Cho, Helena
Peckitt, Clare
Mohammed, Kabir
Matharu, Sheila
Scerri, Lisa
Husson, Olga
Cruickshank, Susanne
Turner, Rachel
Wedlake, Linda
author_facet Lidington, Emma
Hogan, Holly
Gandolfi, Ann
Lawrence, Jane
Younger, Eugenie
Cho, Helena
Peckitt, Clare
Mohammed, Kabir
Matharu, Sheila
Scerri, Lisa
Husson, Olga
Cruickshank, Susanne
Turner, Rachel
Wedlake, Linda
author_sort Lidington, Emma
collection PubMed
description BACKGROUND: To understand our performance with respect to the collection and reporting of patient-reported outcome (PRO) measure (PROM) data, we examined the protocol content, data completeness and publication of PROs from interventional trials conducted at the Royal Marsden NHS Foundation Trust (RM) and explored factors associated with data missingness and PRO publication. DESIGN: From local records, we identified closed, intervention trials sponsored by RM that opened after 1995 and collected PROMs as primary, secondary or exploratory outcomes. Protocol data were extracted by two researchers and scored against the SPIRIT-PRO (PRO protocol content checklist; score 0–100, higher scores indicate better completeness). For studies with locally held datasets, the information team summarized for each study, PRO completion defined as the number of expected (as per protocol) PRO measurements versus the number of actual (i.e. completed) PRO measurements captured in the study data set. Relevant publications were identified by searching three online databases and chief investigator request. Data were extracted and each publication scored against the CONSORT-PRO (PRO manuscript content checklist; scored as SPIRIT-PRO above). Descriptive statistics are presented with exploratory comparisons of point estimates and 95% confidence intervals. RESULTS: Twenty-six of 65 studies were included in the review. Nineteen studies had accessible datasets and 18 studies published at least one article. Fourteen studies published PRO results. Most studies had a clinical (rather than PRO) primary outcome (16/26). Across all studies, responses in respect of 35 of 69 PROMs were published. Trial protocols scored on average 46.7 (range 7.1–92.9) on the SPIRIT-PRO. Among studies with accessible data, half (10/19) had less than 25% missing measurements. Publications scored on average 80.9 (range 36–100%) on the CONSORT-PRO. Studies that published PRO results had somewhat fewer missing measurements (19% [7–32%] vs 60% [− 26 to 146%]). For individual PROMs within studies, missing measurements were lower for those that were published (17% [10–24%] vs 41% [18–63%]). Studies with higher SPIRIT-PRO scores and PROs as primary endpoints (13% [4–22%] vs 39% [10–58%]) had fewer missing measurements. CONCLUSIONS: Missing data may affect publication of PROs. Extent of inclusion of SPIRIT-PRO protocol items and PROs as primary endpoints may improve data completeness. Preliminary evidence from the study suggests a future larger study examining the relationship between PRO completion and publication is warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-022-00529-9.
format Online
Article
Text
id pubmed-9780410
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97804102022-12-24 Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation Lidington, Emma Hogan, Holly Gandolfi, Ann Lawrence, Jane Younger, Eugenie Cho, Helena Peckitt, Clare Mohammed, Kabir Matharu, Sheila Scerri, Lisa Husson, Olga Cruickshank, Susanne Turner, Rachel Wedlake, Linda J Patient Rep Outcomes Research BACKGROUND: To understand our performance with respect to the collection and reporting of patient-reported outcome (PRO) measure (PROM) data, we examined the protocol content, data completeness and publication of PROs from interventional trials conducted at the Royal Marsden NHS Foundation Trust (RM) and explored factors associated with data missingness and PRO publication. DESIGN: From local records, we identified closed, intervention trials sponsored by RM that opened after 1995 and collected PROMs as primary, secondary or exploratory outcomes. Protocol data were extracted by two researchers and scored against the SPIRIT-PRO (PRO protocol content checklist; score 0–100, higher scores indicate better completeness). For studies with locally held datasets, the information team summarized for each study, PRO completion defined as the number of expected (as per protocol) PRO measurements versus the number of actual (i.e. completed) PRO measurements captured in the study data set. Relevant publications were identified by searching three online databases and chief investigator request. Data were extracted and each publication scored against the CONSORT-PRO (PRO manuscript content checklist; scored as SPIRIT-PRO above). Descriptive statistics are presented with exploratory comparisons of point estimates and 95% confidence intervals. RESULTS: Twenty-six of 65 studies were included in the review. Nineteen studies had accessible datasets and 18 studies published at least one article. Fourteen studies published PRO results. Most studies had a clinical (rather than PRO) primary outcome (16/26). Across all studies, responses in respect of 35 of 69 PROMs were published. Trial protocols scored on average 46.7 (range 7.1–92.9) on the SPIRIT-PRO. Among studies with accessible data, half (10/19) had less than 25% missing measurements. Publications scored on average 80.9 (range 36–100%) on the CONSORT-PRO. Studies that published PRO results had somewhat fewer missing measurements (19% [7–32%] vs 60% [− 26 to 146%]). For individual PROMs within studies, missing measurements were lower for those that were published (17% [10–24%] vs 41% [18–63%]). Studies with higher SPIRIT-PRO scores and PROs as primary endpoints (13% [4–22%] vs 39% [10–58%]) had fewer missing measurements. CONCLUSIONS: Missing data may affect publication of PROs. Extent of inclusion of SPIRIT-PRO protocol items and PROs as primary endpoints may improve data completeness. Preliminary evidence from the study suggests a future larger study examining the relationship between PRO completion and publication is warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-022-00529-9. Springer International Publishing 2022-12-22 /pmc/articles/PMC9780410/ /pubmed/36547735 http://dx.doi.org/10.1186/s41687-022-00529-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Lidington, Emma
Hogan, Holly
Gandolfi, Ann
Lawrence, Jane
Younger, Eugenie
Cho, Helena
Peckitt, Clare
Mohammed, Kabir
Matharu, Sheila
Scerri, Lisa
Husson, Olga
Cruickshank, Susanne
Turner, Rachel
Wedlake, Linda
Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
title Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
title_full Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
title_fullStr Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
title_full_unstemmed Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
title_short Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
title_sort assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780410/
https://www.ncbi.nlm.nih.gov/pubmed/36547735
http://dx.doi.org/10.1186/s41687-022-00529-9
work_keys_str_mv AT lidingtonemma assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT hoganholly assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT gandolfiann assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT lawrencejane assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT youngereugenie assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT chohelena assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT peckittclare assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT mohammedkabir assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT matharusheila assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT scerrilisa assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT hussonolga assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT cruickshanksusanne assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT turnerrachel assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation
AT wedlakelinda assessingthecollectionandreportingofpatientreportedoutcomedataininterventionalcancertrialsasingleinstitutionretrospectivesystematicevaluation